EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

EAACI/ENDA position paper on drug provocation testing

Annick Barbaud iD, Lene Heise Garvey iD, Maria Torres iD, Jose Julio Laguna iD, Alessandra Arcolaci iD, Patrizia Bonadonna iD, Kathrin Scherer Hofmeier iD, Anca Mirela Chiriac iD, Josefina Cernadas iD, Jean Christoph Caubet iD, Knut Brockow iD

Allergy · 2024-03 · 79 (3) · 565-579

DOI: 10.1111/all.15996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 28.12.2023. Verfasst von Annick Barbaud und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP. Sorbonne Université, Hôpital Tenon, Service de dermat…. Hauptthemen laut MEDLINE: Drug Hypersensitivity. Die Arbeit wurde bisher 203-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EAACI, European Academy of Allergy and Clinical Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In drug hypersensitivity, drug provocation testing (DPT), also called drug challenge, is the gold standard for investigation. In recent years, risk stratification has become an important tool for adjusting the diagnostic strategy to the perceived risk, whilst still maintaining a high level of safety for the patient. Skin tests are recommended before DPT but may be omitted in low‐risk patients. The task force suggests a strict definition of such low‐risk patients in children and adults. Based on experience and evidence from studies of allergy to beta‐lactam antibiotics, an algorithm on how to adjust DPT to the risk, and when to omit skin tests before DPT, is presented. For other antibiotics, non‐steroidal anti‐inflammatory drugs and other drugs, skin tests are poorly validated and DPT is frequently necessary. We recommend performing DPT with chemotherapeutics and biologicals to avoid unnecessary desensitization procedures and DPT with skin tests negative contrast media. We suggest DPT with anesthetics only in highly specialized centers. Specifics of DPT to proton pump inhibitors, anticonvulsants and corticosteroids are discussed. This position paper provides general recommendations and guidance on optimizing use of DPT, whilst balancing benefits with patient safety and optimizing the use of the limited available resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityChildAdultHumansAnti-Inflammatory Agents, Non-SteroidalContrast MediaMonobactamsbeta Lactam AntibioticsSkin TestsAnti-Bacterial Agents

Stichwörter der Autor:innen

beta-lactam antibioticsdelabelingdrug challengedrug provocation testrisk stratification

Substanzen

Anti-Inflammatory Agents, Non-SteroidalContrast MediaMonobactamsbeta Lactam AntibioticsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP. Sorbonne Université, Hôpital Tenon, Service de dermatologie et allergologie, Paris, France.
  • Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Allergy Unit, Regional University Hospital of Malaga-IBIMA-UMA-ARADyAL, Malaga, Spain.
  • Allergy Unit, Allergo-Anaesthesia Unit, Faculty of Medicine, Hospital Central de la Cruz Roja, Alfonso X El Sabio University, ARADyAL, REI, Madrid, Spain.
  • Immunology Unit, University Hospital of Verona, Policlinico G.B. Rossi, Verona, Italy.

ORCID-Profile: Annick Barbaud, Lene Heise Garvey, Maria Torres, Jose Julio Laguna, Alessandra Arcolaci, Patrizia Bonadonna, Kathrin Scherer Hofmeier, Anca Mirela Chiriac, Josefina Cernadas, Jean Christoph Caubet, Knut Brockow

Förderung

  • EAACI
  • European Academy of Allergy and Clinical Immunology

Zitieren

APA

Barbaud, A., Garvey, L. H., Torres, M., Laguna, J. J., Arcolaci, A., Bonadonna, P., Scherer Hofmeier, K., Chiriac, A. M., Cernadas, J., Caubet, J. C., & Brockow, K. (2024). EAACI/ENDA position paper on drug provocation testing. Allergy, 79(3), 565-579. https://doi.org/10.1111/all.15996

Vancouver

Barbaud A, Garvey LH, Torres M, Laguna JJ, Arcolaci A, Bonadonna P, et al. EAACI/ENDA position paper on drug provocation testing. Allergy. 2024;79(3):565-579. doi:10.1111/all.15996

BibTeX
@article{Barbaud2024,
  author = {Barbaud, Annick and Garvey, Lene Heise and Torres, Maria and Laguna, Jose Julio and Arcolaci, Alessandra and Bonadonna, Patrizia and Scherer Hofmeier, Kathrin and Chiriac, Anca Mirela and Cernadas, Josefina and Caubet, Jean Christoph and Brockow, Knut},
  title = {EAACI/ENDA position paper on drug provocation testing},
  journal = {Allergy},
  year = {2024},
  volume = {79},
  number = {3},
  pages = {565--579},
  doi = {10.1111/all.15996}
}
Kostenlos starten →